Chiosea S, Agaimy A, Nagao T et al (2022) Salivary duct carcinoma. In: WHO Classification of Head and Neck Tumours (WHO Classification of tumours series, 5th ed.; vol.9). https://tumourclassification.iarc.who.int/chapters/52. Accessed 5 February 2024

Nakaguro M, Tada Y, Faquin WC et al (2020) Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment. Cancer Cytopathol 128:693–703. https://doi.org/10.1002/cncy.22288

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kawakita D, Nagao T, Takahashi H et al (2022) Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma. Ther Adv Med Oncol 14. https://doi.org/10.1177/17588359221119538

Even C, Delord J-P, Price KA et al (2022) Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study. Eur J Cancer 171:259–268. https://doi.org/10.1016/j.ejca.2022.05.007

Article  PubMed  CAS  Google Scholar 

Vos JL, Burman B, Jain S et al (2023) Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial. Nat Med 29:3077–3089. https://doi.org/10.1038/s41591-023-02518-x

Article  PubMed  CAS  Google Scholar 

Zahalka AH, Frenette PS (2020) Nerves in cancer. Nat Rev Cancer 20:143–157. https://doi.org/10.1038/s41568-019-0237-2

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ali SR, Jordan M, Nagarajan P et al (2022) Nerve Density and Neuronal Biomarkers in Cancer. Cancers (Basal) 14:4817. https://doi.org/10.3390/cancers14194817

Article  CAS  Google Scholar 

Hernandez S, Serrano AG, Solis Soto LM (2022) The Role of Nerve Fibers in the Tumor Immune Microenvironment of Solid Tumors. Adv Biol (Weinh) 6:e2200046. https://doi.org/10.1002/adbi.202200046

Article  PubMed  CAS  Google Scholar 

Kamiya A, Hiyama T, Fujimura A et al (2021) Sympathetic and parasympathetic innervation in cancer: therapeutic implications. Clin Auton Res 31:165–178. https://doi.org/10.1007/s10286-020-00724-y

Article  PubMed  Google Scholar 

Ye YI, Xie T, Amit M (2023) Targeting the Nerve-Cancer Circuit. Cancer Res 83:2445–2447. https://doi.org/10.1158/0008-5472.CAN-23-1754

Article  PubMed  CAS  Google Scholar 

Winkler F, Venkatesh HS, Amit M et al (2023) Cancer neuroscience: State of the field, emerging directions. Cell 186:1689–1707. https://doi.org/10.1016/j.cell.2023.02.002

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ferreira JN, Hoffman MP (2013) Interactions between developing nerves and salivary glands. Organogenesis 9:199–205. https://doi.org/10.4161/org.25224

Article  PubMed  PubMed Central  Google Scholar 

Magnon C, Hall SJ, Lin J et al (2013) Autonomic nerve development contributes to prostate cancer progression. Science 341:1236361. https://doi.org/10.1126/science.1236361

Article  PubMed  Google Scholar 

Shao JX, Wang B, Yao YN et al (2016) Autonomic nervous infiltration positively correlates with pathological risk grading and poor prognosis in patients with lung adenocarcinoma. Thorac Cancer 7:588–598. https://doi.org/10.1111/1759-7714.12374

Article  PubMed  PubMed Central  CAS  Google Scholar 

Amit M, Takahashi H, Dragomir MP et al (2020) Loss of p53 drives neuron reprogramming in head and neck cancer. Nature 578:449–454. https://doi.org/10.1038/s41586-020-1996-3

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bae GE, Kim H-S, Won KY et al (2019) Lower Sympathetic Nervous System Density and β-adrenoreceptor Expression Are Involved in Gastric Cancer Progression. Anticancer Res 39:231–236. https://doi.org/10.21873/anticanres.13102

Rowe CW, Dill T, Griffin N et al (2020) Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion. Sci Rep 10:1539–1539. https://doi.org/10.1038/s41598-020-58425-5

Article  PubMed  PubMed Central  CAS  Google Scholar 

Grytli HH, Fagerland MW, Fosså SD et al (2014) Association Between Use of β-Blockers and Prostate Cancer-Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease. Eur Urol 65:635–641. https://doi.org/10.1016/j.eururo.2013.01.007

Article  PubMed  CAS  Google Scholar 

Jang H-I, Lim S-H, Lee Y-Y et al (2017) Perioperative administration of propranolol to women undergoing ovarian cancer surgery: A pilot study. Obstet Gynecol Sci 60:170–177. https://doi.org/10.5468/ogs.2017.60.2.170

Article  PubMed  PubMed Central  Google Scholar 

De Giorgi V, Geppetti P, Lupi C et al (2020) The Role of β-Blockers in Melanoma. J Neuroimmune Pharmacol 15:17–26. https://doi.org/10.1007/s11481-019-09876-9

Article  PubMed  Google Scholar 

Sivanesan S, Taskén KA, Grytli HH (2022) Association of β-Blocker Use at Time of Radical Prostatectomy With Rate of Treatment for Prostate Cancer Recurrence. JAMA Netw Open 5:e2145230. https://doi.org/10.1001/jamanetworkopen.2021.45230

Article  PubMed  PubMed Central  Google Scholar 

Brierley JD, Gospodarowicz MK, Wittekind C (2017) TNM Classfication of Malignant Tumours, 8th edn. Wiley-Blackwell, Hoboken, pp 47–49

Nakaguro M, Sato Y, Tada Y et al (2020) Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma Proposal of a Novel Histologic Risk Stratification Model. Am J Surg Pathol 44:526–535. https://doi.org/10.1097/pas.0000000000001413

Article  PubMed  Google Scholar 

Takase S, Kano S, Tada Y et al (2017) Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification. Oncotarget 8:59023–59035. https://doi.org/10.18632/oncotarget.19812

Article  PubMed  PubMed Central  Google Scholar 

Hirai H, Nakaguro M, Tada Y et al (2023) Prognostic value and clinicopathological roles of the tumor immune microenvironment in salivary duct carcinoma. Virchows Arch 483:367–379. https://doi.org/10.1007/s00428-023-03598-3

Article  PubMed  CAS  Google Scholar 

Xu B, Jungbluth AA, Frosina D et al (2019) The immune microenvironment and expression of PD-L1, PD-1, PRAME and MHC I in salivary duct carcinoma. Histopathology 75:672–682. https://doi.org/10.1111/his.13944

Article  PubMed  PubMed Central  Google Scholar 

Alame M, Cornillot E, Cacheux V et al (2020) The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities. Theranostics 10:4383–4394. https://doi.org/10.7150/thno.42986

Article  PubMed  PubMed Central  CAS  Google Scholar 

Myckatyn TM, Mackinnon SE (2004) A review of facial nerve anatomy. Semin Plast Surg 18:5–12. https://doi.org/10.1055/s-2004-823118

Article  PubMed  PubMed Central  Google Scholar 

Zahalka AH, Arnal-Estape A, Maryanovich M et al (2017) Adrenergic nerves activate an angio-metabolic switch in prostate cancer. Science 358:321–326. https://doi.org/10.1126/science.aah5072

Article  PubMed  PubMed Central  CAS  Google Scholar 

Palm D, Lang K, Niggemann B et al (2006) The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer 118:2744–2749. https://doi.org/10.1002/ijc.21723

Article  PubMed  CAS  Google Scholar 

Hicks BM, Murray LJ, Powe DG et al (2013) β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort. Ann Oncol 24:3100–3106. https://doi.org/10.1093/annonc/mdt381

Article